13F Holdings
中文EN

CNMD CONMED Corp

Electromedical & Electrotherapeutic Apparatus · NYSE · SEC CIK 816956 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (2025Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY5.2%
TTM net income YoY-64.5%
TTM EPS YoY-64.5%
Revenue 3-yr CAGR9.6%
Net income 3-yr CAGR—

Margins

Gross margin54.6%
Operating margin7.5%
Net margin3.4%
FCF margin11.0%
EBITDA margin8.7%

Returns

ROE4.7%
ROA2.0%
ROIC (approx.)3.7%
Asset turnover0.59x

Leverage & solvency

Liabilities / assets55.6%
Debt / equity0.81x
Current ratio2.14x
Interest coverage3.30x

Cash quality & payout

Operating cash flow / net income3.63x
Accruals ratio-5.3%
Payout ratio52.6%
Capex / revenue1.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$1.37B$1.31B$1.24B$1.05B$1.01B
Cost of revenue$624.25M$573.98M$568.50M$474.23M$442.60M
Gross profit$750.48M$733.03M$676.25M$571.25M$568.04M
R&D expense$55.88M$54.43M$52.60M$47.15M$43.56M
SG&A expense$591.97M$478.28M$503.04M$454.04M$414.75M
Operating income$102.62M$200.33M$120.60M$70.05M$109.72M
Interest expense$31.09M$37.30M$39.77M$28.91M$35.48M
Pretax income$71.12M$163.03M$80.83M-$70.86M$73.11M
Income tax$24.06M$30.61M$16.37M$9.72M$10.56M
Net income$47.05M$132.42M$64.46M-$80.58M$62.54M
EBITDA$119.77M$216.93M$136.80M$86.11M$126.21M
EPS (basic)1.524.292.10-2.682.14
EPS (diluted)1.514.252.04-2.681.94
Dividends declared per share0.600.800.800.800.80
Weighted avg. shares (diluted)31.15M31.15M31.55M30.04M32.22M
Balance sheet
Cash & equivalents$40.82M$24.46M$24.30M$28.94M$20.85M
Receivables$247.83M$237.73M$242.28M$191.34M$183.88M
Inventory$355.54M$346.72M$318.32M$332.32M$231.64M
Current assets$672.86M$640.01M$615.65M$581.23M$460.12M
PP&E, net$113.33M$115.79M$120.72M$115.61M$108.86M
Goodwill$807.01M$805.36M$806.84M$815.43M$617.53M
Intangibles$582.05M$617.66M$649.48M$681.80M$471.05M
Total assets$2.33B$2.31B$2.30B$2.30B$1.77B
Current liabilities$315.04M$278.13M$310.73M$296.55M$196.65M
Short-term debt$712,000$715,000$708,000$69.75M$12.25M
Long-term debt$834.23M$905.07M$973.14M$985.08M$672.41M
Total debt$834.94M$905.78M$973.85M$1.05B$684.66M
Total liabilities$1.29B$1.34B$1.47B$1.55B$980.58M
Shareholders' equity$1.03B$962.68M$834.22M$745.54M$785.43M
Net debt$794.12M$881.32M$949.55M$1.03B$663.81M
Cash flow statement
Operating cash flow$170.69M$166.97M$125.35M$33.37M$111.77M
Capital expenditure$19.81M$13.08M$19.03M$21.79M$14.87M
Free cash flow$150.88M$153.88M$106.32M$11.58M$96.90M
Investing cash flow-$20.96M-$13.08M-$20.03M-$249.53M-$14.87M
Financing cash flow-$135.82M-$151.00M-$110.43M$225.00M-$101.55M
Depreciation & amortization$17.14M$16.61M$16.20M$16.05M$16.49M
Stock-based compensation$28.32M$25.56M$24.26M$21.73M$16.34M
Dividends paid$24.75M$24.65M$24.50M$23.96M$23.26M

Free plan shows the latest 5 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.